MSR38 Can Logistic Regression (LOR) Better Predict the Significance of the Overall Survival (OS) from Surrogate Endpoints (SES) for Randomized Controlled Trials (RCTS) in Oncology? Insights From a Cross-Tumor Case Study
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1770
https://www.valueinhealthjournal.com/article/S1098-3015(22)03975-4/fulltext
Title :
MSR38 Can Logistic Regression (LOR) Better Predict the Significance of the Overall Survival (OS) from Surrogate Endpoints (SES) for Randomized Controlled Trials (RCTS) in Oncology? Insights From a Cross-Tumor Case Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03975-4&doi=10.1016/j.jval.2022.09.1770
First page :
Section Title :
Open access? :
No
Section Order :
11321